Aura Biosciences (AURA) Balance Sheet: Assets & Liabilities

Aura Biosciences (AURA) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Aura Biosciences reported total assets of $169.43M and total liabilities of $32.52M. Shareholders' equity was $136.91M, down 9.9% from $151.97M a year earlier. Total debt stood at $17.38M against $144.24M in cash and short-term investments, a net cash position of $126.86M. That puts debt-to-equity at 0.13, compared with 0.12 a year earlier.

Aura Biosciences Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Aura Biosciences, Inc. (AURA) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	59.52	31.69	41.06	121.58	149.06	17.39	32.47
Short-Term Investments	84.73	119.40	185.09	67.23	0.00	0.00	0.00
Cash & Short-Term Investments	144.24	151.09	226.15	188.81	149.06	17.39	32.47
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	5.50	1.83	2.41	7.89	4.64	1.06	0.88
Total Current Assets	149.74	160.62	231.79	196.70	153.70	18.46	33.35
Non-Current Assets
Property, Plant & Equipment (Net)	18.45	20.59	22.00	26.04	6.20	3.57	3.63
Long-Term Investments	0.00	0.00	0.00	0.77	0.00	0.00	0.08
Other Non-Current Assets	1.24	1.29	1.28	1.19	0.13	0.08	0.00
Total Non-Current Assets	19.69	21.88	23.28	27.23	6.33	3.65	3.71
Total Assets	169.43	182.50	255.08	223.94	160.03	22.10	37.06
Current Liabilities
Accounts Payable	1.55	2.30	1.79	2.92	2.40	0.61	2.33
Short-Term Debt	3.24	3.15	2.69	2.96	0.62	0.02	0.00
Accrued Liabilities	13.59	3.82	3.45	4.57	4.34	1.77	-
Other Current Liabilities	13.59	0.19	0.94	0.33	4.34	2.04	3.82
Total Current Liabilities	18.38	14.91	12.36	10.46	7.36	2.66	6.15
Non-Current Liabilities
Long-Term Debt	14.13	15.62	16.87	17.90	0.36	0.00	0.05
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.08	0.10
Total Non-Current Liabilities	14.13	15.62	16.87	17.90	0.36	0.08	0.14
Total Liabilities	32.52	30.53	29.23	28.35	7.72	2.74	6.29
Stockholders' Equity
Retained Earnings	-480.42	-374.23	-287.31	-210.90	-152.14	-116.89	-94.68
Accumulated Other Comprehensive Income	-0.10	0.26	0.54	-0.07	0.00	0.00	0.00
Additional Paid-in Capital	617.43	525.93	512.62	406.56	304.45	8.17	7.27
Shares Outstanding	63.59	50.00	49.35	37.77	29.21	-	-
Total Stockholders' Equity	136.91	151.97	225.85	195.58	152.32	19.36	30.76
Total Liabilities & Equity	169.43	182.50	255.08	223.94	160.03	22.10	37.06

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Aura Biosciences Balance Sheet

How much debt does Aura Biosciences have?

Aura Biosciences had total debt of $17.38M as of Dec 31, 2025, against $144.24M in cash and short-term investments. Its debt-to-equity ratio was 0.13. Total debt was $18.77M a year earlier.

What are Aura Biosciences's total assets?

Aura Biosciences reported total assets of $169.43M as of Dec 31, 2025, down 7.2% from $182.50M a year earlier. Total liabilities were $32.52M.

What is Aura Biosciences's shareholders' equity?

Aura Biosciences's shareholders' equity was $136.91M as of Dec 31, 2025, or about $2.15 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition